Answer questions and earn CME/CNE Each year, the American Cancer Society (ACS)
publishes a summary of its guidelines for early cancer detection along with a report on data …

Key Clinical Points Cervical-Cancer Screening with Human Papillomavirus and Cytologic
Cotesting Cervical cancer screening in the United States should not start until the age of 21 …

ABSTRACT A group of 47 experts representing 23 professional societies, national and
international health organizations, and federal agencies met in Bethesda, MD, September …

There is limited access to effective cervical cancer screening programs in many resource‐
limited settings, resulting in continued high cervical cancer burden. Human papillomavirus …

Objectives The next round of the American Society for Colposcopy and Cervical Pathology
(ASCCP)-sponsored cervical cancer screening and management guidelines will …

Objective After excisional treatment, cervical intraepithelial neoplasia grade 2 or worse (CIN
2+) can recur. It is not clear how many negative posttreatment Pap or cotest results are …

Objective Current US guidelines for cotesting recommend that the large numbers of women
who test Pap-negative, but human papillomavirus (HPV)–positive, return in 1 year, and …

Objectives There is growing interest in using human papillomavirus (HPV) genotyping as a
risk-based triage approach for women with atypical squamous cells-undetermined …

A formidable threat to the health of women, cervical carcinoma can be prevented in many
cases with adequate screening. The current guidelines for cervical carcinoma screening …

Objective High-grade Pap results (eg, atypical glandular cells [AGC], atypical squamous
cells cannot rule out HSIL [ASC-H], and high-grade squamous intraepithelial lesion [HSIL]) …